Moderna Says Its mRNA Vaccine For RSV Nearly 84% Effective At Preventing Symptoms In Older Adults In Late-Stage Trial

Reuters (1/17, Wingrove, Leo, Sunny) reports that on Tuesday, Moderna “said...that its experimental messenger RNA vaccine for respiratory syncytial virus (RSV) was 83.7% effective in a late-stage trial at preventing at least two symptoms, such as cough an...